Author: Kaddoura, Malak; AlIbrahim, Malak; Hijazi, Ghina; Soudani, Nadia; Audi, Amani; Alkalamouni, Habib; Haddad, Salame; Eid, Ali; Zaraket, Hassan
Title: COVID-19 Therapeutic Options Under Investigation Cord-id: bg20z050 Document date: 2020_8_6
ID: bg20z050
Snippet: Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identi
Document: Since its emergence in China in December 2019, COVID-19 has quickly spread around the globe causing a pandemic. Vaccination or the development of herd immunity seems the only way to slow down the spread of the virus; however, both are not achievable in the near future. Therefore, effective treatments to mitigate the burden of this pandemic and reduce mortality rates are urgently needed. Preclinical and clinical studies of potential antiviral and immunomodulatory compounds and molecules to identify safe and efficacious therapeutics for COVID-19 are ongoing. Two compounds, remdesivir, and dexamethasone have been so far shown to reduce COVID-19–associated death. Here, we provide a review of the potential therapeutic agents being considered for the treatment and management of COVID-19 patients.
Search related documents:
Co phrase search for related documents- abdominal pain diarrhea and acid dependent: 1
- abdominal pain diarrhea vomiting and acid dependent: 1
- abdominal pain diarrhea vomiting nausea and acid dependent: 1
Co phrase search for related documents, hyperlinks ordered by date